Lam S W, Bauer S R, Guzman J A. Septic shock: the initial moments and beyond[J]. Cleve Clin J Med, 2013, 80(3): 175-184. [2]Hollenberg S M. Vasoactive drugs in circulatory shock[J]. Am J Respir Crit Care Med, 2011, 183(7): 847-855. [3]Rivers E P, Katranji M, Jaehne K A,et al. Early interventions in severe sepsis and septic shock: a review of the evidence one decade later[J]. Minerva Anestesiol, 2012, 78(6): 712-724. [4]Dellinger R P, Levy M M, Rhodes A,et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012[J]. Intensive Care Med, 2013, 39(2): 165-228. [5]Sadaka F, Juarez M, Naydenov S,et al. Fluid resuscitation in septic shock: the effect of increasing fluid balance on mortality[J]. J Intensive Care Med, 2014, 29(4): 213-217. [6]Dellinger R P, Levy M M, Rhodes A,et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012[J]. Crit Care Med, 2013, 41(2): 580-637. [7]Daley M J, Lat I, Mieure K D,et al. A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation of septic shock[J]. Ann Pharmacother, 2013, 47(3): 301-310. [8]Russell J A. Bench-to-bedside review: vasopressin in the management of septic shock[J]. Crit Care, 2011, 15(4): 226. [9]De-Backer D, Biston P, Devriendt J,et al. Comparison of dopamine and norepinephrine in the treatment of shock[J]. N Engl J Med, 2010, 362(9): 779-789. [10]Russell J A, Walley K R, Singer J,et al. Vasopressin versus norepinephrine infusion in patients with septic shock[J]. N Engl J Med, 2008, 358(9): 877-887. [11]周飞虎, 宋青. 去甲肾上腺素与血管加压素改善脓毒症休克预后比较研究Meta分析[J]. 创伤与急危重病医学, 2013, 1(1): 49-53. ？
